Meta‐Analysis of Xihuang Pill Efficacy When Combined with Chemotherapy for Treatment of Breast Cancer

D Mao, L Feng, S Huang, S Zhang… - Evidence‐Based …, 2019 - Wiley Online Library
Objective. To systematically evaluate the efficacy of Xihuang pill (XHP) in breast cancer
patients receiving chemotherapy. Methods. Three English and four Chinese databases were …

Chemotherapy-induced toxicities and their associations with clinical and non-clinical factors among breast cancer patients in Vietnam

SM Nguyen, AT Pham, LM Nguyen, H Cai, TV Tran… - Current …, 2022 - mdpi.com
Understanding the burden and factors related to chemotherapy-induced toxicity is important
in treatment planning for breast cancer patients. We conducted a prospective study among …

Factors influencing fear of cancer recurrence in patients with breast cancer: evidence from a survey in Yancheng, China

L Niu, Y Liang, M Niu - Journal of Obstetrics and Gynaecology …, 2019 - Wiley Online Library
Aim To identify the characteristics of fear of cancer recurrence (FCR) in breast cancer
patients after surgery and investigate the relationship of FCR with demographic and medical …

Patterns of Anthracycline‐Based Chemotherapy‐Induced Adverse Drug Reactions and Their Impact on Relative Dose Intensity among Women with Breast Cancer in …

DA Gadisa, M Assefa, GM Tefera… - Journal of Oncology, 2020 - Wiley Online Library
Background. The breast cancer chemotherapy leads to diverse aspects of noxious or
unintended adverse drug reactions (ADRs) that cause the relative dose intensity (RDI) …

Symptomatic adverse events of chemotherapy in breast cancer patients: Using CTCAE, PRO-CTCAE, and EORTC QLQ-C30

H Arahori, K Kondo, Y Imai, T Bando… - The Journal of Medical …, 2024 - jstage.jst.go.jp
Background: The Common Terminology Criteria for Adverse Events (CTCAE) is used as a
tool to evaluate the adverse events (AE) of chemotherapy in cancer patients. Since CTCAE …

Outcomes of Triple-Negative Breast Cancer Patients in Response to Taxane and Nontaxane-Based Neoadjuvant Chemotherapies

M Khan, Z Alam, SA Siddiqui, M Akram… - Asian Journal of …, 2022 - thieme-connect.com
Introduction Neoadjuvant chemotherapy (NAC) is the standard of care for locally advanced
breast cancer. The achievement of pathological complete response (pCR) in response to …

[PDF][PDF] patients: Using CTCAE, PRO-CTCAE, and EORTC QLQ-C30

H Arahori, MD Soichiro Sasa - The Journal of …, 2024 - medical.med.tokushima-u.ac.jp
Background: The Common Terminology Criteria for Adverse Events (CTCAE) is used as a
tool to evaluate the adverse events (AE) of chemotherapy in cancer patients. Since CTCAE …

[PDF][PDF] Ocena wartości wskaźnika Ki-67 u chorych na raka piersi leczonych neoadjuwantowo

N Kmieć - 2022 - ppm.gumed.edu.pl
Współczesne leczenie raka piersi obejmuje trzy różne metody: chirurgię, leczenie
systemowe oraz radioterapię. Metody te mogą być wykorzystywane w różnych …

Chemotherapy-induced toxicity and its association with clinical factors and gastrointestinal microbiome among breast cancer patients in Vietnam

SM Nguyen - 2022 - search.proquest.com
Chemotherapy can lead to various acute side effects and long-term toxicities, affecting
treatment compliance, efficacy, and long-term outcomes. Growing evidence suggests that …

Cáncer de mama, alteraciones orales derivadas del tratamiento quimioterápico con Everolimus vs Antraciclinas. Revisión sistemática

A Pierotti - 2022 - titula.universidadeuropea.es
El cáncer de mama es una neoplasia maligna que afecta principalmente a las mujeres,
cuya supervivencia se ha visto incrementada por la aplicación de campañas de prevención …